NCT00204490 2024-05-16
Soy Isoflavones and Breast Cancer Risk Reduction
The University of Texas Medical Branch, Galveston
Phase 2 Completed
Clinical Trials
8 trialsNCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT01797120 2018-05-30
PrE0102
PrECOG, LLC.
Phase 2 Completed
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00917735 2016-02-22
Green Tea and Reduction of Breast Cancer Risk
University of Minnesota
Phase 2 Completed
NCT00493636 2014-05-20
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
Accelerated Community Oncology Research Network
Phase 2 Completed
NCT00080743 2009-08-06
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
Dartmouth-Hitchcock Medical Center
Phase 2 Completed